NCT04324229Completed
Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
Source: ClinicalTrials.gov · Last updated 23 Oct 2026
Brief summary (registry, in English)
Obese women with history of gestational diabetes are in great danger to develop type 2 diabetes (T2D) within 5-10 years after delivery. Aim of the study is to investigate if 12 months' liraglutide treatment could decrease the risk of T2D in obese women who have had gestational diabetes. The women are randomized either to liraglutide (Victoza ® 1.8 mg) or placebo group, once daily. Same laboratory tests are taken and instructions given at baseline 6 month and one year. After one year visits once a year until 5 years with same laboratory tests and measurements are taken.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 67 (actual)
- First submitted
- 15 Mar 2020
- Start date
- 7 Feb 2020
- Primary completion date
- 9 Apr 2025
- Lead sponsor
- Turku University Hospital
- Diseases
- Type 2 diabetes
- NCT number
- NCT04324229
What you commit to
- Study type: Interventional
- Participants enrolled: 67
- From 7 Feb 2020 to the primary completion date, 9 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- use of antidepressives, statins or anti-hyperglycemic therapies
Other illness
- type 1 or type 2 diabetes
- severe hepatic insufficiency
- end stage renal disease
- history of pancreatitis
Other
- lactation
- pregnancy
Who the study is looking for
- history of gestational diabetes with treatment with metformin and/or insulin
- delivery 6 to 18 months before screening
- BMI ≥30 kg/m2
- use of contraceptives (IU-device or oral contraceptive)
Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Turku University Hospital Coordinator of this site? Confirm its status | Turku | Finland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.